Skip to main content
PRVA logo

PRVA · Privia Health Group, Inc.

Track PRVA — free
$22.00 +0.24 (+1.10%) At close · Aug 14
Market Cap
$2.81B
Shares
127.73M

Privia Health Group, Inc. Earnings Call Transcripts

Every quarterly earnings call for Privia Health Group, Inc. (PRVA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-06
Privia Health Q2'26 Conference Call
Revenue
$632.63M
▲ 21.4% YoY
Diluted EPS
$0.07
▲ 250% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Privia Health Group, Inc. Q1 FY2026 Earnings Call
Confident tone Medical Cost Trend and Risk Appetite 2026 Guidance and Outlook Value-Based Care Platform and Contracts
Revenue
$603.85M
▲ 25.8% YoY
Diluted EPS
$0.02
▼ 33.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Privia Health Group, Inc. Q4 FY2025 Earnings Call
Confident tone Financial results and profitability Provider growth and footprint expansion Evolent Health ACO acquisition
Revenue
$541.17M*
▲ 17.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Privia Health Group, Inc. Q3 FY2025 Earnings Call
Confident tone MSSP / ACO performance Provider and attribution growth Financial results and margin expansion
Revenue
$580.42M
▲ 32.5% YoY
Diluted EPS
$0.05
▲ 66.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Privia Health Group, Inc. Q2 FY2025 Earnings Call
Confident tone Value-based care diversification MSSP and CMS policy landscape Raised 2025 guidance outlook
Revenue
$521.15M
▲ 23.4% YoY
Diluted EPS
$0.02
▼ 33.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Privia Health Group, Inc. Q1 FY2025 Earnings Call
Confident tone Arizona Market Entry / IMS Acquisition M&A Pipeline & Market Expansion Value-Based Care / Risk Model Philosophy
Revenue
$480.10M
▲ 15.6% YoY
Diluted EPS
$0.03
▲ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Privia Health Group, Inc. Q4 FY2024 Earnings Call
Confident tone Financial performance and EBITDA expansion Provider growth and density Free cash flow and balance sheet strength
Revenue
$460.90M*
▲ 4.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Privia Health Group, Inc. Q3 FY2024 Earnings Call
Confident tone MSSP / Shared Savings Performance Diversified Business Model 2024 Guidance Outlook
Revenue
$437.92M
▲ 4.9% YoY
Diluted EPS
$0.03
▼ 40% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Privia Health Group, Inc. Q2 FY2024 Earnings Call
Confident tone Value-based care and attributed lives Commercial risk and direct-to-employer opportunity Financial performance and 2024 guidance raise
Revenue
$422.33M
▲ 2.2% YoY
Diluted EPS
$0.03
▼ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Privia Health Group, Inc. Q1 FY2024 Earnings Call
Positive tone Financial performance and EBITDA MSSP and value-based contracts Medicare Advantage capitation restructuring
Revenue
$415.24M
▲ 7.5% YoY
Diluted EPS
$0.02
▼ 66.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Privia Health Group, Inc. Q4 FY2023 Earnings Call
Positive tone 2024 Financial Guidance and Profitability Provider Network Expansion Risk Management in Medicare Advantage
Revenue
$440.83M*
▲ 21% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Privia Health Group, Inc. Q3 FY2023 Earnings Call
Revenue
$417.28M
▲ 21.7% YoY
Diluted EPS
$0.05
▲ 400% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Privia Health Group, Inc. Q2 FY2023 Earnings Call
Revenue
$413.35M
▲ 23.2% YoY
Diluted EPS
$0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Privia Health Group, Inc. Q1 FY2023 Earnings Call
Revenue
$386.28M
▲ 23.1% YoY
Diluted EPS
$0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Privia Health Group, Inc. Q4 FY2022 Earnings Call
Revenue
$364.42M*
▲ 32.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Privia Health Group, Inc. Q3 FY2022 Earnings Call
Revenue
$342.90M
▲ 36.3% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Privia Health Group, Inc. Q2 FY2022 Earnings Call
Revenue
$335.54M
▲ 48.6% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Privia Health Group, Inc. Q1 FY2022 Earnings Call
Revenue
$313.80M
▲ 46.9% YoY
Diluted EPS
$-0.16
▼ 366.7% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-22
Privia Health Group, Inc. Q4 FY2021 Earnings Call
Revenue
$275.33M*
▲ 28.8% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Privia Health Group, Inc. Q3 FY2021 Earnings Call
Revenue
$251.52M
▲ 21.4% YoY
Diluted EPS
$-0.09
▼ 152.9% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Privia Health Group, Inc. Q2 FY2021 Earnings Call
Revenue
$225.76M
▲ 23.2% YoY
Diluted EPS
$-1.68
▼ 2900% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-27
Privia Health Group, Inc. Q1 FY2021 Earnings Call
Revenue
$213.61M
▲ 0.3% YoY
Diluted EPS
$0.06
▲ 0% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 279 filings 278 filers Visit website Investor relations